NCT06951308 Efficacy of Carbohydrate Loading in Diabetic Type 2 Patients Undergoing CABG Surgery on CPB
| NCT ID | NCT06951308 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Damascus University |
| Condition | Heart Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-04-01 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Enhanced recovery after surgery protocols aim to optimize perioperative care and improve surgical outcomes. Preoperative carbohydrate loading has demonstrated benefits in reducing insulin resistance and improving patient outcomes. While non-diabetic patients benefit from this approach, its efficacy in diabetic type 2 patients undergoing CABG remains less understood. This study aims to address this gab by evaluating the physiological and clinical outcomes for carbohydrate loading in this specific population.
Eligibility Criteria
Inclusion Criteria: All diabetic type 2 patients undergoing isolated on-pump coronary artery bypass surgery. Exclusion Criteria: * Missing data. * Patients outside the study period. * Patients undergoing other cardiac surgeries. * Patients diagnosed with type 1 diabetes mellitus.
Contact & Investigator
Mohammad B Izzat, FRCS(CTh)
STUDY DIRECTOR
Damascus University
Frequently Asked Questions
Who can join the NCT06951308 clinical trial?
This trial is open to participants of all sexes, studying Heart Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06951308 currently recruiting?
Yes, NCT06951308 is actively recruiting participants. Contact the research team at mbizzat@gmail.com for enrollment information.
Where is the NCT06951308 trial being conducted?
This trial is being conducted at Damascus, Syria.
Who is sponsoring the NCT06951308 clinical trial?
NCT06951308 is sponsored by Damascus University. The principal investigator is Mohammad B Izzat, FRCS(CTh) at Damascus University. The trial plans to enroll 50 participants.